DIRECT COSTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AMONG MANAGED CARE PATIENTS



In-vitro activity of tigecycline against multidrug-resistant Gram negative bacteria: The experience of a university hospital

The emergence of multidrug-resistant Gram negative bacteria has given rise to significant therapeutic challenges.These pathogens may have developed resistance to tigecycline, which is an alternative antibiotic used empirically in the treatment of serious infections.The objectives of this study were to identify the in-vitro activity of tigecycline a

read more